Skip to main content

Risk for T2D Increased for Individuals With Late Chronotype

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 12, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 11, 2024 -- People with a late chronotype have an increased risk for type 2 diabetes (T2D) and have higher body mass index (BMI) and larger waist circumference, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.

Jeroen H.P. van der Velde, Ph.D., from Leiden University Medical Center in the Netherlands, and colleagues calculated the mid-point of sleep (MPS) and defined three chronotypes: late, intermediate, and early (MPS ≥4.00, 2.30 to 4.00, and <2.30) and examined their association with BMI, waist circumference, visceral fat, liver fat, and the risk for T2D in the Netherlands Epidemiology of Obesity study.

A total of 5,026 participants were analyzed in the study; 20 percent had a late chronotype. The researchers found that 225 participants were diagnosed with T2D during a median follow-up of 6.6 years. Participants with a late versus an intermediate chronotype had an increased risk for T2D (hazard ratio, 1.46). Those with a late chronotype also had 0.7 g/m2 higher BMI, 1.9 cm larger waist circumference, 7 cm2 more visceral fat, and 14 percent more liver fat.

"People with a late chronotype appear to be at greater risk of developing type 2 diabetes compared to those with intermediate chronotype, possibly because of higher body fat including more visceral fat and liver fat," van der Velde said in a statement.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss

FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...

In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity

TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...

GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression

MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.